Mutation screening of the BARD1 gene: evidence for involvement of the Cys557Ser allele in hereditary susceptibility to breast cancer

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Journal of Medical Genetics

• Publication date

  2004-09-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1136/jmg.2004.020669PMID 15342711PMCID PMC1735890
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Nuclear–cytoplasmic translocation of BARD1 is linked to its apoptotic activity

  2004cited by this paper
• BRCA1/BARD1 orthologs required for DNA repair in Caenorhabditis elegans.

  2004cited by this paper
• Genome-wide scanning for linkage in Finnish breast cancer families

  2004cited by this paper
• Genome-wide scanning for linkage in Finnish breast cancer families

  2004cited by this paper
• BRCA1 gene in breast cancer

  2003cited by this paper
• Mutational analysis of BARD1 in familial breast cancer patients in Japan.

  2003influential reference
• BARD1 Participates with BRCA1 in Homology-Directed Repair of Chromosome Breaks

  2003cited by this paper
• Breast and ovarian cancer.

  2003cited by this paper
• Loss of Bard1, the Heterodimeric Partner of the Brca1 Tumor Suppressor, Results in Early Embryonic Lethality and Chromosomal Instability

  2003cited by this paper
• BARD1 Induces BRCA1 Intranuclear Foci Formation by Increasing RING-dependent BRCA1 Nuclear Import and Inhibiting BRCA1 Nuclear Export*

  2002cited by this paper
• Identification of Residues Required for the Interaction of BARD1 with BRCA1*

  2002cited by this paper
• Polygenic susceptibility to breast cancer and implications for prevention

  2002cited by this paper
• Review Cancer Susceptibility and the Functions of BRCA1 and BRCA2

  2002cited by this paper
• Low-penetrance susceptibility to breast cancer due to CHEK2*1100delC in noncarriers of BRCA1 or BRCA2 mutations

  2002cited by this paper
• Germline mutations of the BRCA1‐associated ring domain (BARD1) gene in breast and breast/ovarian families negative for BRCA1 and BRCA2 alterations

  2002cited by this paper
• Low-penetrance susceptibility to breast cancer due to CHEK2*1100delC in noncarriers of BRCA1 or BRCA2 mutations

  2002cited by this paper
• A comprehensive model for familial breast cancer incorporating BRCA1, BRCA2 and other genes

  2002cited by this paper
• Cancer susceptibility and the functions of BRCA1 and BRCA2.

  2002cited by this paper
• BRCA1 at a branch point

  2001cited by this paper
• The RING Heterodimer BRCA1-BARD1 Is a Ubiquitin Ligase Inactivated by a Breast Cancer-derived Mutation*

  2001cited by this paper
• The BARD1-CstF-50 interaction links mRNA 3' end formation to DNA damage and tumor suppression.

  2001cited by this paper
• Germline TP53 alterations in Finnish breast cancer families are rare and occur at conserved mutation-prone sites

  2001cited by this paper
• BRCA1 RING Domain Cancer-predisposing Mutations

  2001cited by this paper
• Identification of BARD1 as mediator between proapoptotic stress and p53-dependent apoptosis.

  2001cited by this paper
• Mutation analysis of the CHK2 gene in families with hereditary breast cancer

  2001cited by this paper
• Roles of BRCA1 and its interacting proteins

  2000cited by this paper
• The ankyrin repeat: a diversity of interactions on a common structural framework.

  1999cited by this paper
• Functional interaction of BRCA1-associated BARD1 with polyadenylation factor CstF-50.

  1999cited by this paper
• The Bcl-3 oncoprotein acts as a bridging factor between NF-κB/Rel and nuclear co-regulators

  1999cited by this paper
• Mapping the Functional Domains of BRCA1

  1999cited by this paper
• The genetics of breast cancer susceptibility.

  1998cited by this paper
• In Vitro Repression of Brca1-associated RING Domain Gene, Bard1, Induces Phenotypic Changes in Mammary Epithelial Cells

  1998cited by this paper
• Conformation sensitive gel electrophoresis for simple and accurate detection of mutations: comparison with denaturing gradient gel electrophoresis and nucleotide sequencing.

  1998cited by this paper
• Mutations in the BRCA1-associated RING domain (BARD1) gene in primary breast, ovarian and uterine cancers.

  1998influential reference
• Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium.

  1998cited by this paper
• Evidence of founder mutations in Finnish BRCA1 and BRCA2 families.

  1998cited by this paper
• Cell cycle-dependent colocalization of BARD1 and BRCA1 proteins in discrete nuclear domains.

  1997cited by this paper
• Dynamic changes of BRCA1 subnuclear location and phosphorylation state are initiated by DNA damage.

  1997cited by this paper
• Identification of a RING protein that can interact in vivo with the BRCA1 gene product

  1996cited by this paper
• Identification of the breast cancer susceptibility gene BRCA2

  1996cited by this paper
• Identification of the breast cancer susceptibility gene BRCA2

  1995cited by this paper
• Estimates of the gene frequency of BRCA1 and its contribution to breast and ovarian cancer incidence.

  1995cited by this paper
• A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1.

  1994cited by this paper
• Genetic analysis of breast cancer in the cancer and steroid hormone study.

  1991cited by this paper

• Computational studies on the functional and structural impact of pathogenic mutations in enzymes

  2025cites this paper
• Contribution of BARD1 gene to male breast cancer- report of a family with different types of cancer.

  2025cites this paper
• Functional Analysis of BARD1 Missense Variants on Homology‐Directed Repair in Ovarian and Breast Cancers

  2024cites this paper
• What Is Known about Breast Cancer in Young Women?

  2023cites this paper
• Breast cancer research: in vitro models, markers, and in silico analysis - a narrative review

  2023cites this paper
• Structural dynamics of clinically-reported VUS in the BARD1 ARD-BRCT region to predict the molecular basis of alterations

  2023cites this paper
• BARD1 mystery: tumor suppressors are cancer susceptibility genes

  2022cites this paper
• Germline variants associated with breast cancer in Khakass women of North Asia

  2022cites this paper
• Activation of recombinational repair in Ewing sarcoma cells carrying EWS-FLI1 fusion gene by chromosome translocation

  2022cites this paper
• Structural insight into BRCA1-BARD1 complex recruitment to damaged chromatin.

  2021cites this paper
• A synergetic effect of BARD1 mutations on tumorigenesis

  2021cites this paper
• Stepwise approach to hereditary breast cancer and evaluation of BRCA negative patients

  2021cites this paper
• The Effects of Genetic and Epigenetic Alterations of BARD1 on the Development of Non-Breast and Non-Gynecological Cancers

  2020cites this paper
• Literature Review of BARD1 as a Cancer Predisposing Gene with a Focus on Breast and Ovarian Cancers

  2020influential citation
• Summary of BARD1 Mutations and Precise Estimation of Breast and Ovarian Cancer Risks Associated with the Mutations

  2020cites this paper
• 1 BARD 1 and breast cancer : the possibility of creating 2 screening tests and new preventive and therapeutic 3 pathways for predisposed women 4

  2020cites this paper
• BARD1 and Breast Cancer: The Possibility of Creating Screening Tests and New Preventive and Therapeutic Pathways for Predisposed Women

  2020cites this paper
• Germline variants in DNA repair genes associated with hereditary breast and ovarian cancer syndrome: analysis of a 21 gene panel in the Brazilian population

  2020cites this paper
• The antitumorigenic roles of BRCA1–BARD1 in DNA repair and replication

  2020cites this paper
• Long-term Outcome After Doxorubicin and Ifosfamide Overdose in a Patient With Osteosarcoma and BARD1 Mutation.

  2019cites this paper
• Exploring the Molecular Mechanism of the Drug-Treated Breast Cancer Based on Gene Expression Microarray

  2019cites this paper
• Functional analysis of clinical BARD1 germline variants

  2019cites this paper
• BARD1 is a Low/Moderate Breast Cancer Risk Gene: Evidence Based on an Association Study of the Central European p.Q564X Recurrent Mutation

  2019cites this paper
• Comprehensive Assessment of BARD1 Messenger Ribonucleic Acid Splicing With Implications for Variant Classification

  2019cites this paper
• Identification of a module of HAP transcription factors for seed development in rice

  2019cites this paper
• Biomarker Studies in Early Detection and Prognosis of Breast Cancer.

  2017cites this paper
• A strategy to apply quantitative epistasis analysis on developmental traits

  2017cites this paper
• BRCA1–BARD1 promotes RAD51-mediated homologous DNA pairing

  2017cites this paper
• Dualistic Role of BARD1 in Cancer

  2017cites this paper
• Challenges in Interpreting Germline Mutations in BARD1 and ATM in Breast and Ovarian Cancer Patients

  2017cites this paper
• Molecular Biology In Young Women With Breast Cancer: From Tumor Gene Expression To DNA Mutations.

  2017cites this paper
• Breast cancer genetics in young women: What do we know?

  2017cites this paper
• New concepts on BARD1: Regulator of BRCA pathways and beyond.

  2016cites this paper
• Genomic Biomarkers for Breast Cancer Risk.

  2016cites this paper
• Multimodal approach to explore the pathogenicity of BARD1, ARG 658 CYS, and ILE 738 VAL mutants

  2016cites this paper
• Search for influential genomic changes in breast cancer families

  2015cites this paper
• Genetic predisposition to breast and/or ovarian cancer – focus on the candidate BARD1 gene

  2015cites this paper
• Cancer predisposing BARD1 mutations affect exon skipping and are associated with overexpression of specific BARD1 isoforms.

  2015cites this paper
• Analysis of large mutations in BARD1 in patients with breast and/or ovarian cancer: the Polish population as an example

  2015cites this paper
• The BARD1 BRCT domain contributes to p53 binding, cytoplasmic and mitochondrial localization, and apoptotic function.

  2015cites this paper
• Cancer predisposing BARD 1 mutations affect exon skipping and are associated with overexpression of specific BARD 1 isoforms

  2015cites this paper
• Influencia del consumo de antiinflamatorios no esteroideos en la incidencia de cáncer de mama: = Influence of non-streroidal antiinflammatory drugs use on breast cancer incidence

  2015cites this paper
• Breast c ancer genes: l ooking for Bra ca's l ost Brother

  2014cites this paper
• Breast cancer genes: looking for BRACA's lost brother.

  2014cites this paper
• Alternative splicing in cancer: implications for biology and therapy

  2014cites this paper
• Antibody therapy to limit the spread of Ebola virus.

  2014cites this paper
• Hereditary predisposition to breast cancer – with a focus on AATF , MRG15 , PALB2 , and three Fanconi anaemia genes

  2014cites this paper
• Analiza molekularna kompleksu genów MRE11/RAD50/NBS1 w rodzinach z agregacją zachorowań na raki piersi i/lub jajnika

  2014cites this paper
• Identifying New Genes for Inherited Breast Cancer by Exome Sequencing

  2014cites this paper
• A Cross-Sectional Study of Associations Between Nonsynonymous Mutations of the BARD1 Gene and Breast Cancer in Han Chinese Women

  2013cites this paper
• UCSD MOLECULE PAGES BARD1

  2013cites this paper
• Characterization of BARD1 targeting and dynamics at the centrosome: the role of CRM1, BRCA1 and the Q564H mutation.

  2012cites this paper
• Identification of Functional SNPs in BARD1 Gene and In Silico Analysis of Damaging SNPs: Based on Data Procured from dbSNP Database

  2012influential citation
• The BARD1 Cys557Ser variant and risk of familial breast cancer in a South-American population

  2012cites this paper
• Cancer predisposing BARD1 mutations in breast-ovarian cancer families

  2012cites this paper
• The BRCA1 Breast Cancer Suppressor: Regulation of Transport, Dynamics, and Function at Multiple Subcellular Locations

  2012cites this paper
• Cancer predisposing BARD1 mutations in breast–ovarian cancer families

  2011cites this paper
• Common Genetic Variation at BARD1 Is Not Associated with Breast Cancer Risk in BRCA1 or BRCA2 Mutation Carriers

  2011cites this paper
• BRCA/Fanconi anemia pathway genes in hereditary predisposition to breast cancer

  2011cites this paper
• BARD1 (BRCA1 associated RING domain 1)

  2011cites this paper
• PEDIGREE ANALYSIS OF PATIENTS WITH THERAPY-RELATED MYELOID NEOPLASMS REVEALS GERM-LINE MUTATIONS IN THE DNA DAMAGE RESPONSE GENES BRCA1, BARD1 AND TP53

  2011cites this paper
• BARD1 Expression Predicts Outcome in Colon Cancer

  2011cites this paper
• Null Results in Brief Common Genetic Variation at BARD 1 Is Not Associated with Breast Cancer Risk in BRCA 1 or BRCA 2 Mutation Carriers

  2011cites this paper
• Lack of association between BARD1 Cys557Ser variant and breast cancer risk: a meta-analysis of 11,870 cases and 7,687 controls

  2011influential citation
• Analyse de l'expression de BARD1 dans le cancer du poumon et le cancer colorectal

  2010influential citation
• Cancer predisposing missense and protein truncating BARD1 mutations in non‐BRCA1 or BRCA2 breast cancer families

  2010influential citation
• Mutation screening of the MERIT40 gene encoding a novel BRCA1 and RAP80 interacting protein in breast cancer families

  2010cites this paper
• Genetic analysis of the PI3k/AKT/mTOR signaling pathway

  2010cites this paper
• Genetic sequence variations of BRCA1-interacting genes AURKA, BAP1, BARD1 and DHX9 in French Canadian Families with high risk of breast cancer

  2009cites this paper
• The role of BACH1 , BARD1 and TOPBP1 genes in familial breast cancer

  2009cites this paper
• Other Hereditary Breast Cancer Syndromes and Genes

  2009cites this paper
• The BARD1 Cys557Ser polymorphism and breast cancer risk: an Australian case–control and family analysis

  2009influential citation
• CLSPN AND PALB 2 GENES IN FAMILIAL BREAST CANCER SUSCEPTIBILITY

  2008cites this paper
• Functional role of proteins containing ankyrin repeats

  2008cites this paper
• BARD1 variants are not associated with breast cancer risk in Australian familial breast cancer

  2008cites this paper
• Discovering interactions among BRCA1 and other candidate genes associated with sporadic breast cancer

  2008cites this paper
• DNA repair by HDR in experimental tumorigenesis

  2008cites this paper
• TOPBP1 , CLSPN and PALB2 genes in familial breast cancer susceptibility

  2008cites this paper
• A Role of BRCA1-Associated Protein BARD1 in Oxidative Stress Response and Signaling and Proliferation Control

  2008influential citation
• Genetic Predisposition to Breast and Ovarian Cancer in Eastern Finnish

  2007cites this paper
• Structural Requirements for the BARD1 Tumor Suppressor in Chromosomal Stability and Homology-directed DNA Repair*

  2007cites this paper
• BARD1 Translocation to Mitochondria Correlates with Bax Oligomerization, Loss of Mitochondrial Membrane Potential, and Apoptosis*

  2007cites this paper
• Oncogenic BARD1 isoforms expressed in gynecological cancers.

  2007cites this paper
• Identification of BARD1 splice-isoforms involved in human trophoblast invasion.

  2007cites this paper
• Molecular haplotyping of tandem single nucleotide polymorphisms by allele-specific PCR.

  2007cites this paper
• Balanced t(11;15)(q23;q15) in a TP53+/+ breast cancer patient from a Li-Fraumeni syndrome family.

  2006cites this paper
• BARD1 variants Cys557Ser and Val507Met in breast cancer predisposition

  2006cites this paper
• The BARD1 Cys557Ser Variant and Breast Cancer Risk in Iceland

  2006influential citation
• 3 - Role of Tumor Suppressor BARD1 in Apoptosis and Cancer

  2006cites this paper
• Is there more to BARD1 than BRCA1?

  2006cites this paper
• Aberrant expression of BARD1 in breast and ovarian cancers with poor prognosis

  2006cites this paper
• Nordic collaborative study of the BARD1 Cys557Ser allele in 3956 patients with cancer: enrichment in familial BRCA1/BRCA2 mutation-negative breast cancer but not in other malignancies

  2006cites this paper
• Identification and characterization of missense alterations in the BRCA 1 associated RING domain ( BARD 1 ) gene in breast and ovarian cancer

  2005cites this paper
• Association de l'expression aberrante de "BARD1" à un pronostique défavorable des cancers du sein et de l'ovaire

  2005cites this paper
• Mechanisms of tumour suppression and control of genomic integrity by BARD1

  2005influential citation
• Identification and characterization of missense alterations in the BRCA1 associated RING domain (BARD1) gene in breast and ovarian cancer

  2005cites this paper
• Role for a Bard1 SNP in Breast Cancer Susceptibility

  2005cites this paper
• Nuclear Targeting and Cell Cycle Regulatory Function of Human BARD1*

  2005cites this paper
• Identification and characterization of missense alterations in the BRCA1 associated RING domain (BARD1) gene in breast and ovarian cancer

  2005cites this paper
• ROLE FOR A BARD 1 SNP IN BREAST CANCER SUSCEPTIBILITY

  2005cites this paper